Adimab adds MD Anderson, MSK to its roster of partners; Google names its life sciences biz;

@FierceBiotech: Busy Roche inks another immuno-oncology discovery pact, this time with Pieris. News | Follow @FierceBiotech

@JohnCFierce: In the category of 'can't make this stuff up,' $NWBO issued a followup statement saying why Leary wouldn't work. More | Follow @JohnCFierce

> Adimab signed a pair of collaborations with the University of Texas MD Anderson Cancer Center and the other with Memorial Sloan Kettering, lending its antibody-discovery platform to the oncology institutions as they work to develop new therapies. More

> At the American Society for Hematology meeting, CAR-T immunotherapies struggled to replicate their leukemia success in other types of cancer. News

> Google's ($GOOG) life sciences division has given itself a name, moving forward as Verily. Story

> Galena Biopharma ($GALE) settled stock-pumping allegations for $20 million. Item

Medical Device News

@FierceMedDev: ICYMI yesterday: AstraZeneca, NCI tap French company to develop companion mobile app for cancer drugs. Article | Follow @FierceMedDev

@EmilyWFierce: Google Life Sciences will now be known as "Verily." More | Follow @EmilyWFierce

> FDA gives nod for mini-sponge, gunshot wound dressing device for civilians. Story

> Upstart wins CE mark for first swallowable weight-loss gastric balloon. Article

Pharma News

@FiercePharma: Japan's Kaketsuken at center of major vaccine, blood product records fraud. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: J&J, AbbVie's Imbruvica builds on case for first-line CLL use at ASH. More | Follow @CarlyHFierce

> Beleaguered Daiichi Sankyo shuttering German antibody business. News

> Valeant weighs Paragon sale to get out of FTC spotlight. Story

Drug Delivery News

> 'Smart' hydrogel wound dressing delivers drugs from reservoirs. News

> FDA funds computer simulations in bid to speed up development of long-acting generics. Story

> Clearside closes $20M round for candidates that are injected into the eye's suprachoroidal space. More

> University of Warwick spinout develops first transdermal ibuprofen pain patch. Report

> Metal 'nano-terminator' liquefies on demand to bring cancer down. Article

Pharma Manufacturing News

> FDA gives Sun Pharma go-ahead to manufacture generic version of cancer drug Gleevec. Item

> Associated Press: Taxpayers' tally to entice Novo Nordisk to NC may top $130M. More

> South African health activists protest Sanofi over lack of BCG vaccine. Article

> Catalent production issues at French plant cause delay in GSK launch. Story

> AstraZeneca shuttering Bengaluru, India API plant, citing low demand. Report

Pharma Asia News

> China economy not the main culprit in pharma slowdown, FT says. Article

> Outlook for early 2016 in Asia sees headwinds for Japan, India and Thailand. Report

> Japan's Kaketsuken at center of major vaccine, blood product records fraud. More

> China superbug has already gone global, Danish researcher says. Story

> India a potential center for orphan drug development and demand. Article

Suggested Articles

A delay to Moderna's phase 3 COVID-19 study is part of a trend of tensions in the biotech’s relationship with the U.S. government, Reuters reported.

GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.

Annexon Biosciences and AlloVir are seeking a $100 million IPO apiece in a buoyant market that shows no signs of slowing down.